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Modeling, Substrate Docking, and Mutational Analysis
Identify Residues Essential for the Function and Specificity
of a Eukaryotic Purine-Cytosine NCS1 Transporter*□S
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Athens, Panepistimiopolis, Athens 15771, Greece
Background: The purine-cytosine FcyB transporter is a prototype member of the NCS1 family.
Results:Using homologymodeling, substrate docking, and rationalmutational analysis, we identify residues critical for function
and specificity.
Conclusion: Important aspects concerning the molecular mechanism and evolution of transporter specificity are revealed.
Significance: The first systematic approach on structure-function-specificity relationships in a eukaryotic NCS1 member is
shown.
The recent elucidation of crystal structures of a bacterial
member of the NCS1 family, the Mhp1 benzyl-hydantoin per-
mease from Microbacterium liquefaciens, allowed us to con-
struct and validate a three-dimensionalmodel of theAspergillus
nidulans purine-cytosine/H FcyB symporter. The model con-
sists of 12 transmembrane-helical, segments (TMSs) and cyto-
plasmicN- andC-tails. Adistinct core of 10TMSs ismadeof two
intertwined inverted repeats (TMS1–5 and TMS6–10) that are
followed by two additional TMSs. TMS1, TMS3, TMS6, and
TMS8 form an open cavity that is predicted to host the substrate
binding site. Based on primary sequence alignment, three-di-
mensional topology, and substrate docking, we identified five
residues as potentially essential for substrate binding in FcyB;
Ser-85 (TMS1), Trp-159, Asn-163 (TMS3), Trp-259 (TMS6),
and Asn-354 (TMS8). To validate the role of these and other
putatively critical residues, we performed a systematic func-
tional analysis of relevant mutants. We show that the proposed
substrate binding residues, plus Asn-350, Asn-351, and Pro-353
are irreplaceable for FcyB function.Among these residues, Ser-
85, Asn-163, Asn-350, Asn-351, and Asn-354 are critical for
determining the substrate binding affinity and/or the speci-
ficity of FcyB. Our results suggest that Ser-85, Asn-163, and
Asn-354 directly interact with substrates, Trp-159 and Trp-
259 stabilize binding through - stacking interactions, and
Pro-353 affects the local architecture of substrate binding
site, whereas Asn-350 and Asn-351 probably affect substrate
binding indirectly. Our work is the first systematic approach
to address structure-function-specificity relationships in a
eukaryotic member of NCS1 family by combining genetic and
computational approaches.
Purines and pyrimidines (nucleobases) are absolutely essen-
tial metabolites for all cells, being not only the precursors of
nucleotide andnucleic acid biosynthesis but also being involved
in cell signaling, nutrition, response to stress, and cell homeo-
stasis. Most cells in all domains of life possess specific nucleo-
base transporters, distinct from those involved in the uptake of
nucleosides (1, 2). Nucleobase transporters are important in
protozoan and plant development and in the susceptibility of
human, protozoan, or fungal cells to purine-related drugs
(3–10). Fungi possess three evolutionary distinct families of
transporters specific for nucleobases (2, 11, 12). Members of
one of them, the so called nucleobase cation symport (NCS1,3
also known as purine-related transporter) family, are ubiqui-
tously distributed in all fungi and are present in some eubacte-
ria, archaea (11–14), and plants (15) but are absent in protozoa
and metazoa (see uniprot online). Besides purines, cytosine,
and uracil, other known substrates for NCS1 transporters
include the antifungals 5-fluorocytosine (5-FC), and 5-fluorou-
racil, benzyl-hydantoin, allantoin, thiamine, pyridoxal-based
compounds, and nicotinamide riboside. All NCS1 members of
known function probably act as H symporters, although the
Microbacterium liquefaciens benzyl-hydantoin transporterwas
reported to be a Na symporter (11).
The NCS1 family includes two major subfamilies, the Fcy-
like and the Fur-like transporters (11). Three Fcy-like proteins
of Ascomycetes have been well characterized genetically and
studied with respect to regulation of expression, transport
kinetics, and substrate specificity. These are the Fcy2p (16),
Fcy21p (17), and FcyB (13) permeases of Saccharomyces cerevi-
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siae, Candida albicans, and Aspergillus nidulans, respectively.
All three are involved in high affinity transport of adenine,
hypoxanthine, guanine, cytosine, and 5-FC. The only physio-
logical difference between Fcy2p/Fcy21p and FcyB is that the
two yeast transporters constitute the sole high capacity gate-
ways for purine uptake, whereas in A. nidulans high capacity
purine uptake is catalyzed by another transporter, called AzgA
(17), FcyB acting basically as a cytosine supplier and only sec-
ondarily as a purine carrier (13).
Despite some classical genetic approaches in Fcy2p that
identified several residues critical for substrate or cation bind-
ing and transport (18–20), very little was knownwith respect to
structure-function relationships in NCS1-like transporters
until recently. In 2008, however, the crystal structure of a bac-
terial member of the NCS1 family, namely the Mhp1 benzyl-
hydantoin permease from M. liquefaciens (21), was reported
(22). Surprisingly, the Mhp1 topology has proved to be very
similar to that of several recently revealed structures of other
bacterial transporters that showed no sequence similarity and
exhibited entirely different specificities. These include the
amino acid transporter LeuT (23), the galactose transporter
vSGLT (24), the betaine transporter BetP (25), and two amino
acid transporters, AdiC (26) and ApcT (27). Dysfunction of
members of this growing superfamily in humans is associated
with neurological (28) and kidney disorders (29), cancer (30),
and drug resistance (31). The core of the fold shared by these
transporters is an “inverted repeat” motif with two sets of five
transmembrane helices oppositely orientated with respect to
the membrane (often called the 5HIR-fold) (32–34). The two
extra TMSs (TMS11 and TMS12 in the NCS1 family) do not
seem to participate in transport activity, and their role is
unclear.
Most interestingly, several different conformations have
been observed for these transporters in the recent years. These
can be categorized into three classes: outward-facing, as
observed in LeuT (35, 36), Mhp1 (22), and AdiC (26, 37);
occluded, where a trapped substrate is blocked from exiting on
either side of the protein as seen in LeuT (23), Mhp1 (22), BetP
(25), and AdiC (37); inward-facing, as seen in Mhp1 (34),
vSGLT (24), ApcT (27), and LeuT (36). Up to date, Mhp1 and
LeuT are the only transporters trapped into three structural
conformations associated with transport catalysis. From analy-
ses of these three structures and molecular dynamics simula-
tions, amechanismhas been proposed for the transport cycle in
Mhp1 or LeuT (34, 36, 38). Switching from the outward- to the
inward-facing state goes through occluded states and is primar-
ily achieved by a rigid bodymovement of several TMSs (e.g. 3, 4,
8, and 9 in Mhp1) relative to a rather rigid bundle of helices (1,
2, 6, and 7 in Mhp1). In the occluded transient states, “thin
gates” involving only a few residues in specific TMSs (e.g. 5 and
10 inMhp1) and parts of loops control the opening and closing
of the substrate binding site to the exterior or interior. This
forms the basis of an alternating access mechanism applicable
to probably all transporters of the 5HIR superfamily (32–34, 36,
39). Evidently, details of substrate transport, especially those
concerning the occlusion mechanism, remain largely contro-
versial because models have been derived by comparing trans-
porters with divergent amino acid sequences that transport a
wide variety of substrates and that possibly select and transport
different ions (Na versusH) for driving the symport of their
major substrates (34, 36, 38). Furthermore, what is often
ignored is that all available structures concern prokaryotic
transporters, which despite being similar to important mam-
malian carriers, also present significant structural and bio-
chemical differences. For example, eukaryotic transporters
possess long N- and C-tails or longer hydrophilic loops, absent
in prokaryotes, that are often associated with transporter sub-
cellular trafficking, function, specificity, stability, or topology
(40–42).
In this work we construct and validate a three-dimensional
model of the A. nidulans purine-cytosine FcyB transporter
based on the outward facing substrate-occluded crystal struc-
ture of the Mhp1 benzyl-hydantoin permease fromM. liquefa-
ciens (PDB entry 2JLO). Subsequently, we use this model to
perform independent docking studies and thus identify resi-
dues that might be involved in substrate binding and transport.
Most importantly, we experimentally validate our speculations
on specific amino acid residues by a systematic functional anal-
ysis of relevant mutants. Our work is discussed with respect to
the molecular determinants underlying substrate specificity in
the NCS1 family.
EXPERIMENTAL PROCEDURES
Homology Modeling—Proteins with significantly similar
structural-fold with FcyB were identified using HHpred. All
5HIR transporters showed significant similarity with FcyB, but
onlyMhp1 showed a 100% probability (E value 1.8E55; p value
6.6 E60). Homology model building was performed using
MODELLER v.9.8 software (43).
Protein Preparation—The protein was prepared for docking
calculations using the Protein Preparation Workflow
(Schrödinger Suite 2011 Protein Preparation Wizard) imple-
mented in the Schrödinger suite and accessible fromwithin the
Maestro program (Maestro, Version 9.2, Schrödinger, LLC,
NY, 2011). Briefly, hydrogen atoms were added, and the orien-
tation of hydroxyl groups, Asn, Gln, and the protonation state
of His were optimized to maximize hydrogen bonding. Finally,
the ligand-protein complex was refined with a restrained min-
imization performed by Impref utility that is based on the
Impact molecular mechanics engine (Impact Version 5.7,
Schrödinger, LLC, NY, 2011) and the OPLS2001 force field,
setting a max root mean square deviation of 0.30 (44). Ligand
preparation for docking was performed with LigPrep (LigPrep,
Version 2.5, Schrödinger, LLC, NY, 2011) application that con-
sists of a series of steps that perform conversions, apply correc-
tions to the structure, generate ionization states and tautomers,
and optimize the geometries.
MolecularDynamic Simulations—For themolecular dynam-
ics simulations, Desmond v.3 software was implemented (Des-
mond Molecular Dynamics System, Version 3.0, D. E. Shaw
Research, NY). The system was prepared by embedding the
protein in a 1-palmitoyl-2-oleylphosphatidylcholine (POPC)
lipid bilayer, solvating the membrane by TIP4P explicit water,
neutralizing with counter ions, and adding 150 mM salt and
subsequently following the stepwise equilibration protocol as
developed by Desmond for membrane proteins (45). The ori-
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entation of the protein in the bilayer was determined by using
the Mhp1 template available in OPM database (46). An 18-ns
simulation was performed in the NPT ensemble with Lan-
gevin thermostat and barostat and semi-isotropic pressure
restraints (supplemental Fig. S1).
Induced Fit Docking—Molecular docking was performed
using the induced fit docking (IFD) protocol (Schrödinger Suite
2011 Induced Fit Docking protocol) that is intended to circum-
vent the inflexible binding site and accounts for the side chain
or backbone movements or both upon ligand binding (47). In
the first stage of the IFD protocol, softened-potential docking
step, 20 poses per ligand were retained. In the second step for
each docking pose, a full cycle of protein refinement was per-
formed with Prime 1.6 (Prime, Version 3.0, Schrödinger, LLC,
NY, 2011) on all residues having at least one atom within 8.0 Å
of an atom in any of the 20 ligand poses. The Prime refinement
starts with a conformational search and minimization of the
side chains of the selected residues, and after convergence to a
low energy solution, an additional minimization of all selected
residues (side chain and backbone) is performed with the trun-
cated-Newton algorithm using the OPLS parameter set and a
surface Generalized Born implicit solvent model. The obtained
complexes are ranked according to Prime calculated energy
(molecular mechanics and solvation), and those within 30 kcal/
mol of theminimumenergy structure are used in the last step of
the process, redocking with Glide 5.7 (Glide, Version 5.7,
Schrödinger, LLC, NY, 2011) using standard precision and
scoring. In the final round, the ligands used in the first docking
step are redocked into each of the receptor structures retained
from the refinement step. The final ranking of the complexes is
done by a composite score that accounts for the receptor-ligand
interaction energy (GlideScore) and receptor strain and solva-
tion energies (Prime energy).
Media, Strains, Growth Conditions, and Transformation
Genetics—Standard complete and minimal media (MM) for
A. nidulans were used. Media and supplemented auxotrophies
were at the concentrations given online in fgsc. Nitrogen
sourceswere used at the final concentrations, 5mMurea, 10mM
NaNO3, 0.5 mM purines. Escherichia coli was grown on Luria-
Bertani medium. Media and chemical reagents were obtained
from Sigma or AppliChem (Bioline Scientific SA, Hellas,
Greece). Transformations were performed as described previ-
ously (48). A single-copy plasmid integration of the FcyB served
as a standard wild-type control. A fcyB::argB; uapA;
uapC::AFpyrG; azgA; riboB2; pabaA1 mutant strain (13)
was the recipient strain in transformations with the wild-type
pAN520, the pAN530, the pAN540 (see below), or the mutant
FcyB alleles carried on the above vectors. As a negative, trans-
formants with empty pAN vectors were used. These vectors
allow selection of transformants based on p-aminobenzoic acid
(pabaA1) or riboflavin (riboB2) auxotrophy complementation.
Transformants expressing intact fcyB or fcyB-gfp alleles,
through either single-copy or multi-copy plasmid integration
events, were identified by PCR and Southern analysis. For the
relative subcellular localization of wild-type or mutant N81A
FcyB-GFP with mRFP-tagged histone H1 (HhoA-mRFP),
appropriate strainswere constructed by standard genetic cross-
ing. The strain harboringHhoA-mRFP is reported in Edgerton-
Morgan and Oakley (49). Growth tests were performed at 25
and at 37 °C, pH 6.8.
Plasmid Constructions and FcyB Mutations—pAN520 is a
modified pBluescript KS() vector (Stratagene) based on the
plasmid pAN510 (50) that carries the FcyB orf cloned in-frame
between the 5 and 3 regulatory sequences of the uapA gene
and also carrying the pabaA gene as a selection marker (13).
pAN530 and pAN540 are similar to pAN520, but in this case
the fcyB and the fcyB fused C- or N-terminally with the gfp
together with the 5 and 3 regulatory sequences of the uapA
gene were cloned in the pGEMTM-T vector (Promega), also
carrying the riboB gene from Aspergillus fumigatus as a selec-
tion marker. Mutations were constructed by site-directed
mutagenesis according to the instructions accompanying the
QuikChange site-directedmutagenesis kit (Stratagene) on the
above vectors andwere confirmed by sequencing.Oligonucleo-
tides used for cloning and site-directed mutagenesis purposes
are listed in supplemental Table S1.
Standard Nucleic Acid Manipulations—Genomic DNA
extraction from A. nidulans was as described in fgsc. Plasmid
preparation from E. coli strains and DNA bands were purified
from agarose gels donewith theNucleospin Plasmid kit and the
Nucleospin ExtractII kit according to the manufacturer’s
instructions (Macherey-Nagel, Lab Supplies Scientific SA, Hel-
las, Greece). Southern blot analysis was performed as described
previously (51). [32P]dCTP-labeled molecules used as fcyB-,
riboB-, or pabaA-specific probeswere prepared using a random
hexanucleotide primer kit following the supplier’s instructions
(Takara Bio, Lab Supplies Scientific SA) and purified on
MicroSpinTM S-200 HR columns following the supplier’s
instructions (Roche Diagnostics). Labeled [32P]dCTP (3000
Ci/mmol) was purchased from the Institute of Isotopes Co. Ltd,
Miklós, Hungary. Restriction enzymes were from Takara Bio.
Conventional PCR reactions were done with KAPATaq DNA
polymerase (Kapa Biosystems, Lab Supplies Scientific SA).
Cloning and amplification of products were done with Pfx Plat-
inum (Invitrogen) or Phusion Flash High-fidelity PCR Mas-
terMix (New England Biolabs, Lab Supplies Scientific SA).
Membrane Protein Extraction and Western Blot Analysis—
Cultures for membrane protein extraction were grown in MM
supplemented with urea at 37 °C for 8 h. Membrane protein
extraction was performed as previously described (52). Equal
sample loading was estimated by Bradford assays. Total pro-
teins (30g) were separated by SDS-PAGE (10%w/v polyacryl-
amide gel) and electroblotted (Mini PROTEAN™ Tetra Cell,
Bio-Rad) onto PVDF membranes (Macherey-Nagel, Lab Sup-
plies Scientific SA) for immunodetection. The membrane was
treated with 3% (w/v) BSA, and immunodetection was per-
formed with a primary mouse anti-GFP monoclonal antibody
(Roche Diagnostics) or a mouse anti-actin monoclonal (C4)
antibody (MP Biomedicals Europe, Lab Supplies Scientific SA)
and a secondary goat antimouse IgGHRP-linked antibody (Cell
Signaling Technology Inc., Bioline Scientific SA). Blots were
developed by the chemiluminescent method using the
LumiSensor Chemiluminescent HRP Substrate kit (Genscript
USA, Lab Supplies Scientific SA) and SuperRX Fuji medical
X-Ray films (FujiFILM Europe, Lab Supplies Scientific SA).
Structure-Function Relationships in FcyB
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Kinetic Analysis—[3H]Hypoxanthine (19.6–33.4 Ci/mmol,
Moravek Biochemicals, CA) uptake in MMwas assayed in ger-
minating conidiophores of A. nidulans concentrated at 107
conidiospores/100 l at 37 °C, pH 6.8, as previously described
(40, 53). Initial velocities were measured at 1 min of incubation
with concentrations of 0.2–2.0 M [3H]hypoxanthine at the
polarity maintenance stage (3–4 h, 130 rpm). Km/i values were
obtained directly by performing and analyzing uptakes (Prism
3.02: GraphPad Software) using labeled hypoxanthine at 0.2–
0.5 M or at various concentrations (0.5–2000 M) of non-la-
beled substrates. Ki values were calculated by satisfying the cri-
teria for use of the Cheng and Prusoff equation Ki IC50/(1
(L/Km)) in which L is the permeant concentration. IC50 values
were determined from full dose-response curves, and in all
cases the Hill coefficient was close to 1, consistent with the
presence of one binding site. Reactions were terminated with
the addition of equal volumes of ice-coldMMcontaining 1000-
fold excess of non-radiolabeled substrate. Background uptake
values were corrected by subtracting either values measured in
the deleted mutants or values obtained in the simultaneous
presence of 1000-fold excess of non-radiolabeled substrate.
Both approaches led to the same background uptake level, not
exceeding 10–15% of the total counts obtained in wild-type
strains. All transport assays were carried out in at least three
independent experiments, with three replicates for each con-
centration or time point. S.D. was 20%.
Epifluorescence Microscopy—Samples for fluorescence micros-
copywere prepared as previously described (52). In brief, germ-
lings incubated on coverslips in liquid MM supplemented with
NaNO3 as the nitrogen source for 12–14 h at 25 °C were
observed on an Axioplan Zeiss phase-contrast epifluorescent
microscope, and the resulting images were acquired with a
Zeiss-MRC5 digital camera using the AxioVs40 V4.40.0 soft-
ware. Image processing, contrast adjustment, and color com-
bining were made using the Adobe Photoshop CS4 Extended
Version 11.0.2 software or the ImageJ software. Images were
converted to 8-bit grayscale or RGB and annotated using Pho-
toshop CS4 before being saved to TIFF.
RESULTS
FcyB Structural Model—The construction of a structural
model of FcyB was based on the crystal structure of the Mhp1
benzyl-hydantoin permease from M. liquefaciens (PDB entry
2JLO (22)). The two proteins share a rather moderate sequence
similarity (18% identity), which is, however, adequate for sus-
taining a theoretical model of FcyB. The model built here was
based on the alignment of the two proteins, as shown in a mul-
tiple alignment including all NSC1 carriers with known func-
tion, which was further modified manually (Fig. 1). Model
building was performed using MODELLER software. The loop
refinement routine and a slow simulated annealing protocol for
model refinement were implemented. As a first validation of
the model, the structure with the best spatial restraints score
was subjected to a 18-ns molecular dynamics run using Des-
mond software. The system was prepared by embedding the
protein in a POPC lipid bilayer and solvating the membrane by
explicit water. The root mean square deviation of the trans-
membrane helices -carbons from starting coordinates was
monitored throughout the simulation and did not exceed 3 Å,
thus indicating the stability of the theoretical model.
The overall three-dimensional structure of the FcyB model
(Fig. 2) corresponds to an outward-facing conformer made of
12 TMSs that adopt a mostly helical secondary structure. The
architecture of the transporter divides it in two distinct
domains, a compact core consisting of segments TMS1–10 and
a C-terminal domainmade of TMS11–12. The transmembrane
helices in the core are connected with rather short loops (14
amino acid residues), whereas the loop separating the core and
TMS11–12 is longer (23 residues). The distribution of the ion-
ized residues on the protein surface is reasonable, as most of
them are positioned either at the cytoplasmic and periplasmic
sides or along the protein pore in the protein interior. Positive
charges are mostly concentrated in the cytoplasm-facing loops.
The core of FcyB is subdivided in two inverted repeats made of
TMS1–5 and TMS6–10, arranged in a 2-fold pseudosymmetry
axis, running parallel with themembrane plane. The two repeat
units are completely intertwined, giving two topologically dis-
tinct subdomains made of TMSs 1, 2, 6, and 7 and TMSs 3, 4, 8,
and 9, respectively, linked with helices TMS5 and TMS10. As
will be shown below, the substrate binding site is located in the
space between the two subdomains of the core (see Fig. 2B).
Substrate Docking in FcyB—Using the FcyBmodel, aspects of
substrate recognition were addressed using docking calcula-
tions. The four major physiological substrates, namely hypox-
anthine, adenine, guanine, and cytosine, as well as the antifun-
gal 5-FC were docked to the modeled structure of FcyB.
Calculations were performed using the IFD protocol as intro-
duced by the Schrödinger 2011 Suite of programs. The IFD
protocol is based on an iterative implementation of Glide algo-
rithm for rigid docking and Prime algorithm for protein refine-
ment, resulting in an improved simulation of binding in terms
of protein flexibility. Furthermore, because Prime is amodeling
tool especially developed for refinement of protein structures
derived by homology, its implementation as part of the IFD
protocol was considered in the case of FcyB as promising. The
best orientation for each substrate was finally selected on the
basis of lowest energy, number of intermolecular interactions,
and visual inspection.
Fig. 3 shows the modeled interactions of FcyB with its four
physiological substrates and the antifungal 5-FC. FcyB interacts
with adenine through a bidentate H bond that is formed
between Asn-163 and ligand sites C6-NH2 and N1, an H bond
between Ser-85 and purine N7, and - stacking of the purine
ring between the indole rings of Trp-159 andTrp-259 (Fig. 3A).
FcyB interacts with hypoxanthine and guanine through the
establishment of three H bonds between Asn-163 and N1-H,
between Ser-85 and C2AO2, and between Asn-354 and N3, as
well as - stacking of the purine ring between Trp-159 and
Trp-259 (Fig. 3, B and C). Finally, FcyB interacts with cytosine
and its toxic analog 5-FC by forming three H bonds between
Asn-163 and N3, between Asn-354 and ligand C4-NH2, and
between Ser-85 and C2AO2 as well as - stacking with Trp-
159 and Trp-259 (Fig. 3, D and E).
These results establish that Asn-163 and the two invariable
Trp residues, Trp-159 and Trp-259, interact with similar posi-
tions of the rings of all purines and cytosine, whereas the inter-
Structure-Function Relationships in FcyB
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actions involving Ser-85 and Asn-354 vary depending on the
substrate docked. As will be shown and discussed later, muta-
tional analysis strongly support the docking results. In addition,
the model and docking analysis showed that two neighboring
Asn residues, Asn-350 and Asn-351, might interact with Asn-
354 in a way that probably builds a necessary architecture for
substrate binding (see also supplemental Fig. S2). The impor-
tance of residues Asn-350 and Asn-351 in substrate binding
was rigorously established through mutational analysis in this
work (see later). Finally, in the dockingmodels for purine bind-
ing, Ser-261 was also within H bond distance from either N3
(adenine) or N9-H (hypoxanthine, guanine). However, in this
case, mutational analysis did not support the involvement of
Ser-261 in direct substrate binding (see also later).
FIGURE 1.Multiple sequence alignment of FcyB and NCS1 homologues of known function. The three-dimensional FcyB model was constructed on the
basis of the alignment shownwithMhp1. Putative TMSs of FcyB are denoted in colored cylinders. Invariant and highly conserved amino acids are shaded in red
and blue-lined boxes, respectively. Amino acids critical for function and specificity discussed in the Results are highlighted with asterisks: red for residues
interacting with substrates, blue for those critical for substrate binding and transport, and black for other residues discussed in the Results. The listed NCS1
homologues include: FcyB of A. nidulans, GI: 169798762; AfFcyB of A. fumigatus (Af_FcyB), GI: 169798764; Fcy21p of S. cerevisiae, GI: 392860008; Fcy2p of
S. cerevisiae, GI: 6320897; Mhp1 ofM. liquefaciens, GI: 210060746; FurA of A. nidulans, GI: 2876438; Fur4p of S. cerevisiae, GI: 6319495; Dal4p of S. cerevisiae, GI:
392860728; Fui1p of S. cerevisiae, GI: 6319429; FurD of A. nidulans, GI: 149212441; AtNcs1 of Arabidopsis thaliana; GI: 16648836. All Fcy-like proteins are
purine-cytosine transporters. Fur4p and FurD are uracil transporters. FurA and Dal4p are allantoin transporters. Fui1p is a uridine transporter. AtNCS1 is
reported to be specific for adenine-guanine-uracil transport, but no direct information on its ability to transport other nucleobases exists (15).
FIGURE 2. FcyB structuralmodel. A, shown is themodeled three-dimensional structure of FcyB validatedwithmolecular dynamics using Desmond software.
B, shown is the top view of the FcyBmodel where the core of the first 10 TMSs is clearly distinguished from the last two TMSs 11 and 12, which probably do not
affect transport catalysisper se. The core can also be seen as two subdomains, the firstmadeof TMSs 1, 2, 6, and 7 and the second fromTMSs 3, 4, 8, and 9, linked
with flexible helices TMS5 and TMS10. The substrate binding site is located in the space between the two subdomains of the core. In the lower panel, the
topology of residues critical for the function of the substrate binding site, Ser-85, Trp-159, Asn-163, Trp-259, Asn-350, Asn-351, Pro-353, and Asn-354, is shown
in zoom-out.C, shown is the side viewof the FcyB structure showing the topologyof residues Ser-85, Trp-159, Asn-163, Trp-259, andAsn-354, involved indirect
interactions with substrates (see also Fig. 3). Residues Thr-191 and Glu-206 are also shown (see Results). TMS regions are highlighted with colors as in Fig. 1.
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Rational Design and Construction of FcyB Mutants—Results
derived from docking methodologies suggested that five resi-
dues in FcyB might be directly involved in substrate binding.
These are Ser-85 in TMS1, Trp-159 and Asn-163 in TMS3,
Trp-259 in TMS6, and Asn-354 in TMS8. Two more Asn resi-
dues, Asn-350 and Asn-351, might also interact with Asn-354
in a way that is critical for substrate binding. Five of these puta-
tively functional residues, Trp-159, Asn-163, Trp-259, Asn-
350, and Asn-354, superimpose with amino acid residues,
which have been shown to directly interact with the substrate
(benzyl-hydantoin) in Mhp1, namely Trp-117, Gln-121, Trp-
220, Asn-314, and Asn-318. Interestingly, these residues are
either absolutely (Trp-117, Asn-314, and Asn-318) or highly
(Trp-220 and Gln-121) conserved in the NCS1 family (see Fig.
FIGURE 3. Substrate docking in FcyB. A, adenine. B, hypoxanthine. C, guanine. D, cytosine. E, 5-FC. Hydrogen bonds are depicted with dashed lines.
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1). Given the different substrate specificities ofNCS1members,
this suggests that some other residues might also be critical for
substrate binding, a prediction supported in this work (see
later).
To test the functional role of the residues discussed above, as
well as residues differentially conserved inNCS1members with
different specificity profiles or residues positioned close to the
proposed binding site, we constructed a series of relevantmuta-
tions and analyzed functionally the corresponding mutants.
The 19 mutations made were: 81A, N81S, S85A, V83N,
W159A, N163Q, N163L, T191A, E206A, W259A, S261A,
N350Q, N350D, N350A, N351A, P353A, N354Q, N354D,
N354A (See supplemental Table S2). The rationale for the spe-
cific changes constructed was either to introduce Ala or highly
conserved residues or replace FcyB residueswith those found in
other NCS1 members with different specificity.
All mutations were made in vectors carrying the FcyB orf
expressed from the uapA promoter (see “Experimental Proce-
dures”). This was so because the endogenous fcyB promoter is
very weakly expressed under all conditions tested (13). The
uapA gene encodes a verywell studied uric acid-xanthine trans-
porter (for reviews, see Refs. 2 and 12), and thus we used its
promoter, which drives low but significant transcription. Fur-
thermore, the uapA promoter can be totally repressed in the
presence of ammonium ions or glutamine and can be induced
in the presence of uric acid or the gratuitous induced 2-thiox-
anthine (54). In all constructs fcyB transcription is terminated
by the 3-flanking region of uapA. In one set of constructs, the
FcyB orf was fused in-frame with the gfp orf. All plasmids were
introduced in a strain lacking all endogenous purine transport-
ers (“Experimental Procedures”).
Phenotypic Analysis of FcyB Mutants—We analyzed all
selected transformants on different purines as sole nitrogen
sources together with positive and negative isogenic control
strains. A summary of this analysis of transformants express-
ing single-copy FcyB plasmids is shown in Fig. 4A. The positive
control strain expressing wild-type FcyB from the uapA pro-
moter can grow on adenine and hypoxanthine as sole nitrogen
sources and is sensitive to 5-FC. The negative control strain
lacking FcyB cannot grow in any purine and is resistant to 5-FC.
Based on our previous experience with A. nidulans transport-
ers, anymutation reducing steady state rates of purine uptake to
50% that of the wild-type rate is clearly reflected in relevant
growth tests. Transport reductions to levels50% do not lead
to distinguishable growth phenotypes. As expected, all strains
showed normal growth on nitrogen sources other than purines
(e.g. urea). None among the FcyB alleles conferred a capacity for
growth on other purines, such as uric acid or xanthine, which
are not physiological substrates for the wild-type FcyB (not
shown).Within the limits of growth testing on hypoxanthine or
adenine and sensitivity to 5-FC, FcyB mutants could be classi-
fied into apparent wild-type-like (E206A), total loss-of function
(N81A, W159A, N163L, W259A, N350Q, P353A, N354D), or
partial loss-of function (V83N, S261A) or altered specificity
FIGURE 4. Functional analysis of FcyB mutations. A, shown are growth tests on purines as sole nitrogen sources and resistance/sensitivity test on 5-FC at
25 °C. AD is adenine, and HX is hypoxanthine. Growth on urea is also shown (UR) as a control. Positive (FcyB) and negative (FcyB) isogenic control strains are
shown. B, epifluorescence microscopy showing in vivo subcellular expression of FcyB-GFP mutant alleles and a wild-type control (FcyB) is presented as dark
structures inagrayscale invertedmode. In selected samples,arrowsandarrowheadsdepictperinuclear ERmembrane rings (verifiedbyDAPI staining; not shown)
and vacuoles, respectively. C, comparative initial uptake rates of 3H-radiolabeled hypoxanthine in FcyBmutant alleles and awt control are shown. 100% is the
transport rate in the wt (FcyB). D, Western blot analysis of total proteins from FcyB-GFP mutants detected with anti-GFP antibody is shown. Antibody against
actin was used as an internal marker for equal loading.
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showing differential capacities to grow on adenine, hypoxan-
thine, or 5-FC (T191A, N163Q, N350A, N350D, N351A,
N354A, N354Q). In particular, mutants T191A, N351A,
N354A, and N354Q grow better on adenine than on hypoxan-
thine, but in addition, T191A has wild-type like 5-FC sensitiv-
ity, whereas the other three mutants are significantly resistant
to this toxic analog. In contrast, N163Q andN350A grow better
on hypoxanthine than on adenine, but in addition, N163Q is
resistant to 5-FC, whereas N350A has wild-type-like 5-FC sen-
sitivity. N350D does not grow on hypoxanthine and adenine
but is 5-FC-sensitive. The conclusions from this growth test
are: (i) Asn-351 and Asn-354 are very important for hypoxan-
thine and 5-FC (and probably cytosine) transport but less for
adenine, (ii) Asn-163 is more important for 5-FC but less criti-
cal for adenine transport and even less for hypoxanthine trans-
port, (iii) Asn-350 is more critical for the transport of adenine
and less for hypoxanthine 5-FC, and (iv) T191 seems critical
solely for hypoxanthine transport.
Apparent Purine Transport Rates in FcyBMutants—Weper-
formed comparative radiolabeled hypoxanthine uptake meas-
urements in the strains shown in Fig. 4A. Our results (Fig. 4C)
were in line with growth tests. All mutants characterized as
loss-of-function had no or extremely low (V  6%) apparent
uptake capacity for hypoxanthine. Partial loss-of-function
mutations had 33–53% apparent uptake capacity, and E206A
showed 150% transport capacity compared with wild type.
Specificity mutants had low rates for hypoxanthine transport
(2–15% that of the wild-type) except N350A (67%). These
results showed that most amino acid residues tested, except
Glu-206 and to a certain degree Val-83 and Ser-261, are critical
for FcyB transport activity and substrate specificity.
Expression Levels and Cytoplasmic Localization of Mutant
Versions of FcyB—Reduced apparentV values could imply FcyB
problematic trafficking, high turnover, or bona fide reduction
in transport activity. To distinguish among these possibilities,
we reconstructed relevant FcyB alleles tagged with GFP and
performed Western blots and epifluorescence microscopic
analyses.
Western blot analysis of total proteins isolated by the
mutants probed with anti-GFP showed that the FcyB protein
steady state levels are either similar or increased (up to 6-fold)
comparedwith the wild type (Fig. 4D). Increased protein steady
state levels are in principle due to either increased intrinsic
stability, often associated with reduced transport function, or
due to reduced vacuolar turnover due to ER retention.
Epifluorescence microscopic analysis of the same mutants
confirmed that the FcyB-GFP protein was expressed in all
mutants and further revealed that in several mutants (N81A,
S85A, N163Q, N163L, T191A, N350D, N351A, N354Q,
N354D,N354A) FcyB-GFPhad increased ER retention relevant
to the wild-type FcyB-GFP protein (Fig. 4B). In fungi, the ER
membrane appears mostly as very characteristic perinuclear
rings, as verified by Hoechst 33242 or DAPI staining, or by
fluorescent labeling of an ER resident chaperone (55–57). We
have previously shown that transporters with problematic traf-
ficking are mostly retained in these ER perinuclear rings (11,
40). We also verified the identity of the FcyB-GFP-labeled ER
perinuclear rings in a relative mutant (N81A), by nuclei stain-
ing, and by examining the relative localization of these rings
with histone H1 labeled with mRFP (supplemental Fig. S3).
Noticeably, in some mutants (e.g. N81A) the FcyB-GFP signal
intensity does not correspond to the protein steady state levels
detected by anti-GFP (see Fig. 4D). This discrepancy between
higher GFP signals in the cells and low level detection byWest-
ern analysis is not uncommon and is probably due to partial
misfolding of proteins that might differentially affect protein
turnover and GFP visualization. Also, noticeable is the obser-
vation that in mutants with more prominent ER retention the
protein levels of FcyB-GFP are often higher than in wild type,
probably due to reduced vacuolar turnover.
Mutants related to residues Trp-159, Trp-259, and Pro-353
show a subcellular localization picture similar to wild type (no
significant ER-retention), so that their lack of function should
be directly associated to lack of transport activity. In mutants
showing problematic FcyB trafficking, such as those concern-
ing polar residues Asn-81, Ser-85, Asn-163, T191, Asn-350,
Asn-351, and Asn-354, we cannot rigorously conclude whether
the relevant residues are critical for transport activity per se or
whether they affect transport activity indirectly due to partial
misfolding. However, the fact that most of these mutants con-
serve minimal activity allowed us to perform a kinetic analysis
and show that they are indeed critical for substrate binding (see
below).
Specificity Profile of FcyB Mutants—We performed direct
radiolabeled hypoxanthine uptake competition assays to define
the binding constants (Km/is) of FcyB for its physiological sub-
strates in the relevant mutants (for details see “Experimental
Procedures”). We could only perform transporter kinetics in
mutants that preserve a measurable uptake rate of hypoxan-
thine. These were S85A, V83N,N163Q, T191A, E206A, S261A,
N350D, N350A, N351A, and N354D. Given that Km/i values do
not depend on the number of transporter molecules expressed
in the plasmamembrane, for mutants showing very low hypox-
anthine uptake ( 6%), such asN350D,N351A, andN354D, we
used multicopy transformants for performing the kinetic anal-
ysis. Table 1 summarizes the results obtained. The mutants
analyzed could be classified to those little affecting substrate
binding (V83N, T191A, E206A, S261A, N350D) and those
modifying significantly and, in most cases, differentially the
binding of various substrates (N163Q, N350A, N351A,
N354D).Among the latter,N163Q leads to a 4-fold reduction in
TABLE 1
Kinetic and specificity profile of mutant versions of FcyB
Km/i values (M) were determined as described under “Experimental Procedures.”
500 or1000 stand for inhibition values close to 10–20% at 0.5 and 1mM, respec-
tively. Results are averages of at least three independent experiments in triplicate for
each concentration point. S.D. was20%.
Hypoxanthine Adenine Guanine Cytosine
WT 11 7 17 20
V83N 16 2 7 18
S85A 78 26 16 45
N163Q 47 2 500 73
T191A 9 11 4 3
E206A 6 7 10 14
S261A 4 6 50 17
N351A 3 1 4 16
N350D 5 8 31 6
N350A 6 1000 25 5
N354D 3 1 500 4
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the binding of hypoxanthine or cytosine,30-fold reduction in
guanine binding, and a 3.5-fold increase in adenine binding.
N350A conserves binding affinities for hypoxanthine, guanine,
and cytosine close to those of the wild-type (moderately
increased binding for hypoxanthine and cytosine) but exhibits a
dramatic loss of adenine binding (	i 1000 M). N351A has a
general tendency to bind with higher affinity (4–7-fold) all
purines, but not cytosine. Finally, N354D has a 4-fold increased
capacity for hypoxanthine, adenine, and cytosine binding but a
dramatic loss of guanine binding (	i 500M).Noticeably, the
dramatic differential effect of mutation N350A on the ability of
FcyB to bind adenine versus hypoxanthine or cytosine binding
was nicely reflected in growth tests showing that N350A grows
better onhypoxanthine than on adenine and is sensitive to 5-FC
(see Fig. 4A). In summary, kinetic analysis of mutants showed
that residues Asn-163, Asn-350, and Asn-354 are critical for
substrate specificity, whereas Asn-163 and Asn-350 are mostly
critical for substrate binding affinities.
DISCUSSION
Evidence from structural studies and molecular simulations
have strongly supported the proposal that the transporters of
the 5HIR superfamily function by an alternating access mech-
anism in which substrate binding triggers a conformational
change from an outward-facing open conformation through an
occluded structure to the an inward-facing open state of the
protein (32–34, 36, 39). However, many aspects of this mecha-
nism, as for example the exact steps along the substrate and ion
translocation pathway or how gating operates in each case,
remain to be investigated. Our current work did not intend to
approach the alternating mechanism of transport by members
of the 5HIR superfamily. It rather focused on the identification
of specific residues that determine the function, transport
kinetics, and substrate specificity of a eukaryoticmember of the
NCS1 family.
The first part of our work presents a theoretical structural
model of the FcyB purine-cytosine transporter that reveals a
number of important aspects concerning how this transporter
might bind and transport its substrates. To validate the theo-
retical conclusions, we proceeded in a systematic mutational
analysis of putatively critical residues. Our experimental results
fully support the involvement of specific residues in TMS1,
TMS3, TMS6, and TMS8 in substrate binding and/or trans-
port. In particular, residues Ser-85, Trp-159, Asn-163, Trp-259,
Asn-350, Asn-351, Pro-353, and Asn-354 were shown to be
irreplaceable for FcyB-mediated transport. Among these resi-
dues, Ser-85, Asn-163, Asn-350, Asn-351, and Asn-354 seem
critical for determining the substrate binding affinity and/or
specificity of FcyB (see Fig. 4 andTable 1). Among the irreplace-
able amino acids, Asn-163 and Asn-351 might also affect FcyB
stability or/and turnover as the GFP-tagged versions of these
alleles are significantly blocked in the ER compared with the
wild-type protein. The other residues analyzed, Asn-81, Val-83,
Ser-261, Thr-191, and Glu-206, seem to have a less critical role
on protein turnover or FcyB transport activity. Only mutation
T191A moderately affects the affinity and substrate specificity
of FcyB. Noticeably, E206A, a residue within TMS5 that has
been reported to function as a putative inward-facing gate,
leads to a reduction in FcyB turnover and an increase in appar-
ent transport capacity (see Fig. 4).
Among the eight residues essential for FcyB function and
specificity, Trp-159, Asn-163, Trp-259, Asn-350, and Asn-354
correspond to residues shown to be directly involved in sub-
strate binding by the Mhp1 transporter (Trp-117, Gln-121,
Trp-220, Asn-314, and Asn-318). Ser-85 is similarly, but not
identically positioned, with Gln-42 in Mhp1, which is also
involved in substrate binding. The rest two essential FcyB resi-
dues, Asn-351 and Pro-353, are within hydrogen bonding dis-
tance with residues proposed to be involved in direct substrate
binding such that they may hold the local architecture of the
binding site in a position to interact with substrates. Thus, FcyB
and Mhp1, despite their important specificity difference and
overall low amino acid sequence identity, share very similar
residues to build their substrate binding sites; four residues are
identical (Trp-159, Trp-259, Asn-350, and Asn-354, number-
ing of FcyB), one is highly conserved (Asn-163 of FcyB replaced
byGln-121 inMhp1), and three are not conserved (Ser-85,Asn-
351, and Pro-353 in FcyB versus Gln-42, Pro-315, and Ala-317
in Mhp1). In fact, the four absolutely conserved residues
between FcyB and Mhp1 are also highly conserved in all NCS1
members, whereas the other four residues are differentially
conserved among different homologues (see Fig. 1). In particu-
lar, Asn-163 is conserved in nearly all purine-cytosine Fcy-like
NCS1 members, replaced by a Glu residue in a plant adenine-
guanine-uracil transporter (AtNcs1), by a Gln in homologues
specific for uracil (Fur4p/FurD) or allantoin (Dal4p/FurA), and
by a Leu in a uridine-specific transporter (Fui1p). Asn-351 and
Pro-353 are conserved inmicrobial NCS1members specific for
purine-cytosine (Fcy-like proteins) but are replaced by Ile and
Ala in the plant adenine-guanine-uracil transporter (AtNcs1)
and the uracil- or allantoin-specific transporters (Fur4p, FurD,
FurA, andDal4p) or by Leu andGly in a uridine-specific homo-
logue (Fui1p). Interestingly, Ser-85, a major amino acid in FcyB
function, is not a conserved residue in the NCS1 family.
None of the single mutations constructed and analyzed in
this work, including N163L, N163Q, or P353A, which intro-
duce residues present in uracil, allantoin, hydantoin, or uridine
transporters, conferred to FcyB the ability to bind or/and trans-
port substrates other than adenine, guanine, hypoxanthine, and
cytosine (results not shown). In fact, mutationsN163L, N163Q,
or P353A led to loss or highly reduced transport capacity of
FcyB. This observation strongly suggests that substrate speci-
ficity has a more complex molecular basis and might not even
be solely determined by the architecture of the binding site but
also by elements acting as gates or selectivity filters or by ele-
ments contributing to protein stability. We have arrived at a
similar conclusion with respect to the role of interdomain syn-
ergy in determining the specificity of another group of purine
transporters, the nucleobase-ascorbate transporter (NAT/
NCS2) family, which was extensively studied in our laboratory
(40–42).
A genetic analysis of Fcy2p, a true orthologue of FcyB in
S. cerevisiae, supports results presented in this work. Geneti-
cally selected and subsequent site-directed mutations have
strongly suggested a major role of residues Asn-374, Pro-376,
and Asn-377, equivalent to Asn-351, Pro-353, and Asn-354 in
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FcyB, in substrate binding (18–19). Noticeably, the effects of
mutations in Asn-374 and Asn-377 were partially due to a shift
of the pKa of an ionizable amino acid residue of the unliganded
transporter (18). Interestingly, mutation S272L in TMS6, iso-
lated as an allele nonspecific, second-site, suppressor of loss-of-
function mutations T213I, N374I, or N377G, partially restored
the binding of hypoxanthine and cytosine (19).
Based on the above comparative observations, the docking
resultswith FcyB, and themutational analysis presented herein,
we propose that residues corresponding to Trp-159, Trp-259,
Asn-350, Pro-353, and Asn-354 in FcyB are major elements of
the substrate binding site in all NCS1 members, whereas resi-
dues corresponding to Ser-85, Asn-163, and Asn-351 are
mostly specificity determinants. We propose that residues Ser-
85, Asn-163, andAsn-354make direct H-bondswith substrates
and Trp-159 and Trp-259 stabilize binding through--stack-
ing interactions with the purine or pyrimidine ring, whereas
residues Asn-350, Asn-351, and Pro-353 have an indirect role
in substrate binding through local interactions between them-
selves and the residues binding substrates. The critical role of
residues of the four Asn residues, Asn-163, Asn-350, Asn-351,
and Asn-354, in FcyB function and specificity is strongly sup-
ported by both growth phenotypes and kinetic profiles of the
corresponding mutants (Fig. 4A and Table 1). For example,
FcyB-N350A binds similarly to wild-type FcyB hypoxanthine,
guanine, and cytosine but has lost the capacity for adenine
binding. FcyB-N350Dhas increased binding affinity specifically
for hypoxanthine and 5-FC, but only the latter is transported
efficiently. N354D or N163Q have specifically lost the ability to
bind guanine. Finally, N351A, N354A, and N354Q transport
adeninemuchmore efficiently than hypoxanthine and 5-FC, as
deduced from the growth tests shown in Fig. 4A (a similar
growth phenotype is also exhibited by N351I; results not
shown).
Our work is the first systematic functional analysis of a
eukaryotic member of the NCS1 family that, moreover, is com-
bined with theoretical approaches concerning the three-di-
mensional transporter structure. Given the privilege of the sev-
eral Mhp1 crystal structures available corresponding to
different conformations achieved during transport catalysis, we
are now in a position to perform a second round of rational
mutagenesis combinedwith unique genetic screens available in
A. nidulans to understand in more detail not only how FcyB
works and selects its substrates but also how substrate specific-
ity has evolved within the NCS1 family.
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